Susquehanna Fundamental Investments’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-831	Closed	-$58K	–	1724
2021 Q4	$58K	Sell	831 -5,131	-86%	-$432K	﹤0.01%	1359
2021 Q3	$556K	Buy	5,962 +2,099	+54%	+$199K	0.01%	1148
2021 Q2	$388K	Buy	3,863 +947	+32%	+$92.3K	0.01%	1266
2021 Q1	$272K	Buy	+2,916	New	+$296K	﹤0.01%	1319

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Susquehanna Fundamental Investments's VBIV Position: Q1 2022 in Review

Susquehanna Fundamental Investments sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2022, closing a stake of 831 shares — an estimated $58K sold.

Susquehanna Fundamental Investments first reported a position in VBIV in Q1 2021 and held it in 4 quarters. The position peaked at $556K in Q3 2021. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

Susquehanna Fundamental Investments reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 831 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022, an estimated $58K.
Susquehanna Fundamental Investments first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 4 quarters.
Susquehanna Fundamental Investments's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $556K in Q3 2021.
131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.